ArticleFrontiers in pharmacology2019

The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice.

Julien Vollaire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.